Pediatric Eye Disease Investigator Group Selected Research

Pediatric Eye Disease Investigator Group Research Topics

37	Amblyopia (Lazy Eye) 01/2022 - 08/2001
9	Strabismus (Squint) 10/2022 - 12/2005
7	Anisometropia 01/2019 - 06/2006
4	Refractive Errors (Refractive Error) 10/2022 - 06/2007
4	Exotropia (Exophoria) 01/2022 - 10/2016
3	Retinopathy of Prematurity (Retrolental Fibroplasia) 10/2022 - 12/2018
3	Lacrimal Apparatus Diseases (Epiphora) 10/2008 - 03/2008
2	Esotropia (Esophoria) 01/2021 - 02/2016
2	Astigmatism 01/2019 - 10/2007
2	Hyperopia (Hypermetropia) 01/2019 - 10/2007
2	Lacrimal Duct Obstruction 05/2009 - 10/2008
2	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2008 - 05/2007
1	Optic Atrophy 10/2022
1	Neuromyelitis Optica (Devic's Disease) 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2022
1	Multiple Sclerosis 01/2022
1	Diplopia (Double Vision) 01/2021
1	Rupture 12/2016
1	Intraoperative Complications 12/2016
1	Ocular Motility Disorders (Convergence Insufficiency) 12/2016
1	Tonic Pupil 02/2016
1	Glaucoma 06/2012

22	Atropine FDA LinkGeneric 02/2015 - 08/2001
5	Ophthalmic Solutions (Eye Drops)IBA 02/2015 - 02/2005
3	Bevacizumab (Avastin)FDA Link 10/2022 - 12/2018
2	Mydriatics (Cycloplegics)IBA 01/2019 - 06/2007
2	Levodopa (L Dopa)FDA LinkGeneric 05/2015 - 09/2010
1	Retinaldehyde (Retinal)IBA 10/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022
1	Capsules (Microcapsules)IBA 12/2016
1	hemoglobin P (Hb P)IBA 12/2016
1	Type A Botulinum Toxins (Botox)FDA Link 02/2016
1	dimemorfan (AT 17)IBA 12/2008
1	altersolanol AIBA 10/2004

11	Therapeutics 04/2021 - 04/2005
8	Eyeglasses (Spectacles) 01/2022 - 06/2006
6	Telescopes 01/2022 - 10/2007
6	Aftercare (After-Treatment) 04/2021 - 12/2005
4	Operative Surgical Procedures 01/2020 - 03/2008
2	Catheters 05/2009 - 10/2008
1	Lasers (Laser) 10/2021
1	Intraocular Lenses (Intraocular Lens) 12/2016
1	Lenses 10/2016
1	General Anesthesia 06/2012
1	Withholding Treatment 10/2004